Express News | Rigel Pharmaceuticals Inc : Jefferies Cuts Target Price to $12 From $14.5
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Intrinsic Value Is Potentially 87% Above Its Share Price
Express News | Rigel Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Optime Care Announces Enhanced Partnership With Rigel Pharmaceuticals for GAVRETO Patients
Rigel Pharmaceuticals (NASDAQ:RIGL Shareholders Incur Further Losses as Stock Declines 12% This Week, Taking Three-year Losses to 82%
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Rigel Pharmaceuticals To Carry Out 1-for-10 Reverse Stock Split On June 27th, 2024
Faraday Future Plans Another Reverse Split -- Market Talk
Sector Update: Health Care Stocks Advance Pre-Bell Tuesday
Rigel Pharmaceuticals: Shares to Begin Trading on Post-Split Basis When Market Opens June 27 >RIGL
Express News | Rigel Announces Reverse Stock Split
Rigel Pharmaceuticals Sets 1-for-10 Reverse Stock Split >RIGL
Express News | Rigel Pharmaceuticals Inc -Gavreto Will Be Available From Rigel in U.S. Beginning June 27, 2024
Express News | Rigel Pharmaceuticals Completes Transfer of Gavreto® (Pralsetinib) New Drug Application
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $15
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
Rigel to Present at the Jefferies Global Healthcare Conference
Rigel Pharmaceuticals' Strategic Resolutions at 2024 Annual Meeting